DARE - セルリアン・ファ―マ (Dare Bioscience Inc.)

DAREのニュース

   Dare Bioscience Inc. Shares Close the Week 22.6% Lower - Weekly Wrap  2021/01/29 22:30:00 Kwhen Finance
Dare Bioscience Inc. shares closed this week 22.6% lower than it did at the end of last week. The stock is currently up 68.7% year-to-date, up 91.5% over the past 12 months, and down 5.8% over the past five years. This week, the Dow Jones Industrial Average fell 3.3%, and the S&P 500 fell 3.3%. Trading Activity Shares traded as high as $3.01 and as low as $2.00 this week.Shares closed 2e+1% below its 52-week high and 2e+2% above its 52-week low.Trading volume this week was 16.3% lower than the 10-day average and 48.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 6.0% lower than its 5-day moving average, 17.8% higher than its 20-day moving average, and 71.3% higher than its 90-day moving average. Market Comparative Performance The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 33.5% The company's stock price performance over the past 12 months lags the peer average by -28.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Dare Bioscience Inc. Shares Close the Week 102.8% Higher - Weekly Wrap  2021/01/22 22:30:00 Kwhen Finance
Dare Bioscience Inc. shares closed this week 102.8% higher than it did at the end of last week. The stock is currently up 117.9% year-to-date, up 71.8% over the past 12 months, and up 22.2% over the past five years. This week, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 1.9%. Trading Activity Shares traded as high as $3.85 and as low as $1.41 this week.Shares closed 3% below its 52-week high and 3e+2% above its 52-week low.Trading volume this week was 50.4% lower than the 10-day average and 37.1% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 97.6% The company's stock price performance over the past 12 months lags the peer average by -46.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Dare Bioscience Inc. Shares Close the Week 24.8% Higher - Weekly Wrap  2020/12/24 22:30:00 Kwhen Finance
Dare Bioscience Inc. shares closed this week 24.8% higher than it did at the end of last week. The stock is currently up 72.0% year-to-date, up 61.3% over the past 12 months, and down 62.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $1.48 and as low as $1.20 this week.Shares closed 2e+1% below its 52-week high and 8e+1% above its 52-week low.Trading volume this week was 5.7% higher than the 10-day average and 25.2% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -31.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Dare Bioscience Inc. Shares Close the Week 22.6% Lower - Weekly Wrap  2021/01/29 22:30:00 Kwhen Finance
Dare Bioscience Inc. shares closed this week 22.6% lower than it did at the end of last week. The stock is currently up 68.7% year-to-date, up 91.5% over the past 12 months, and down 5.8% over the past five years. This week, the Dow Jones Industrial Average fell 3.3%, and the S&P 500 fell 3.3%. Trading Activity Shares traded as high as $3.01 and as low as $2.00 this week.Shares closed 2e+1% below its 52-week high and 2e+2% above its 52-week low.Trading volume this week was 16.3% lower than the 10-day average and 48.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 6.0% lower than its 5-day moving average, 17.8% higher than its 20-day moving average, and 71.3% higher than its 90-day moving average. Market Comparative Performance The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 33.5% The company's stock price performance over the past 12 months lags the peer average by -28.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Dare Bioscience Inc. Shares Close the Week 102.8% Higher - Weekly Wrap  2021/01/22 22:30:00 Kwhen Finance
Dare Bioscience Inc. shares closed this week 102.8% higher than it did at the end of last week. The stock is currently up 117.9% year-to-date, up 71.8% over the past 12 months, and up 22.2% over the past five years. This week, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 1.9%. Trading Activity Shares traded as high as $3.85 and as low as $1.41 this week.Shares closed 3% below its 52-week high and 3e+2% above its 52-week low.Trading volume this week was 50.4% lower than the 10-day average and 37.1% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 97.6% The company's stock price performance over the past 12 months lags the peer average by -46.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Dare Bioscience Inc. Shares Close the Week 24.8% Higher - Weekly Wrap  2020/12/24 22:30:00 Kwhen Finance
Dare Bioscience Inc. shares closed this week 24.8% higher than it did at the end of last week. The stock is currently up 72.0% year-to-date, up 61.3% over the past 12 months, and down 62.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $1.48 and as low as $1.20 this week.Shares closed 2e+1% below its 52-week high and 8e+1% above its 52-week low.Trading volume this week was 5.7% higher than the 10-day average and 25.2% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -31.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   NASA patented a faster, cheaper route to the moon. The first spacecraft to use it could make Nobel Prize-winning discoveries about the universe.  2020/09/02 12:28:00 Business Insider
NASA patented an efficient new trajectory for sending smaller robotic spacecraft to the moon. The agency says it patents and licenses technologies to ensure they can achieve the "widest distribution" possible. The new trajectory may help a planned spacecraft, called the Dark Ages Polarimeter Pathfinder, reach lunar orbit and repeatedly fly through a "cone of silence" on the far side of the moon . That spacecraft could detect signals from the first stars, galaxies, black holes, and more, leading to big discoveries about how the universe evolved to its current form. Visit Business Insider's homepage for more stories . The moon is both seductively close to Earth and cosmically far away: Decades after the end of the Space Race, it remains extraordinarily expensive and difficult to actually get there. The journey just got a bit easier, however, thanks to a freshly published NASA invention. The agency's patent doesn't cover a new piece of equipment or lines of code, but a trajectory — a route designed to save a lunar-bound mission time, fuel, and money and boost its scientific value.

calendar